Tel : 0086-021-5165-9050 / 0086-15618223367 Email : sales@atkchmemical.com
戊柔比星
ATK-19946
98.00%
56124-62-0
C34H36F3NO13
723.64
Article number Size Operate
ATK-19946 10MG 10MG Inquiry
ATK-19946 20MG 20MG Inquiry
Detection information
Purity: 99.99%
Product Details
CAS Number 56124-62-0 Appearance
Catalog NO ATK-19946 MDL Number
Molecular Formula C34H36F3NO13 Molecular Weight 723.64
Boiling Point 135-136 C Melting Point
Flash Poin Density 1.3473 (estimate)
Synonyms Valrubicin;[2-Oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate;AD-32;ad32;antibioticad32;N-(trifluoroacetyl)adriamycin 14-valerate (AD 32);N-trifluoroacetyladriamycin-14-valerate;N-trifluoroacetyldoxorubicin-14-valerate;trifluoroacetyl-adriamyci14-valerate;Valstar;Vinorelbine (BICINS );Pentanoicacid,2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethylester (9CI);Pentanoic acid,2-[1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethylester, (2S-cis)-;N-Trifluoroacetyladriamycin14-valerate;N-Trifluoroacetyldoxorubicin 14-valerate;NSC 246131;Trifluoroacetyladriamycin 14-valerate;AD 32;Antibiotic AD 32;VALRUBICIN (USP-RS);VALRUBICIN [VANDF];NSC246131;VALRUBICIN [WHO-DD];56124-62-0;2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-{[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetamido)oxan-2-yl]oxy}-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate;Valrubicina;[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate;BRD-K72951360-001-01-4;(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-alpha-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8(2)-valerate;NCGC00390545-01;SCHEMBL12824;2C6NUM6878;DTXSID9046497;HSDB 7288;VALRUBICIN (MART.);Valrubicin (USAN:USP:INN);ZOCKGBMQLCSHFP-KQRAQHLDSA-N;DTXCID7026497;Tox21_112257;D02697;AT20560;VALRUBICIN [MI];CHEMBL1096885;Pentanoic acid, 2-((2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetylamino)-, alpha-L-lysohexopyranoxyl)oxy)-2-naphthacenyl)-2-oxoethyl ester;VALRUBICIN [MART.];2-oxo-2-((2S,4S)-2,5,12-trihydroxy-4-((2R,4S,5S,6S)-5-hydroxy-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2-yloxy)-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)ethyl pentanoate;NSC-246131;CHEBI:135876;AKOS027327568;VALRUBICIN [USP IMPURITY];BDBM50248236;DB00385;Valrubicin Intravesical Solution;HY-13772;Valrubicin [USAN:USP:INN];AD32;Trifluoroacetyladriamycin-14-valerate;2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate;N-Trifluoroacetyladriamycin 14-valerate;VALRUBICIN (USP IMPURITY);EN300-19806784;(2S-cis)-Pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-...
Storage Condition
Safety
GHS Pictogram
Signal Word UN Number
Hazard Statements Class
Precautionary Statements Packing Group
Description
There is currently no product overview available!